These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 14167236)
41. [CONTROL OF AND EXPERIMENTATION WITH DRUGS]. MONNEROT-DUMAINE Presse Med (1893); 1963 Sep; 71():1786-8. PubMed ID: 14091591 [No Abstract] [Full Text] [Related]
42. [Communication of the board of directors of the Pharmacological Society and the commission drawing up directions for testing of new drugs]. Pharmakotherapia; 1964; 2(1):195-207. PubMed ID: 5875713 [No Abstract] [Full Text] [Related]
43. DEPENDENCE ON BARBITURATES AND OTHER SEDATIVE DRUGS. ALTMAN I; KROEGER HH; CLARK DA; JOHNSON AC; SHEPS CG JAMA; 1965 Aug; 193():673-7. PubMed ID: 14321535 [No Abstract] [Full Text] [Related]
44. ADDICTION TO DEXTROMORAMIDE. THOMPSON BA Br Med J; 1964 Oct; 2(5417):1136. PubMed ID: 14198742 [No Abstract] [Full Text] [Related]
45. [Drugs: from research to consumer]. Krankenpflege (Frankf); 1978 Nov; 32(11):366-8. PubMed ID: 213643 [No Abstract] [Full Text] [Related]
46. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION. KELSEY FO J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363 [No Abstract] [Full Text] [Related]
48. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE. KLUMPP TG J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357 [No Abstract] [Full Text] [Related]
49. AMBULATORY WITHDRAWAL TREATMENT OF HEROIN ADDICTS. BERLE BB; NYSWANDER M N Y State J Med; 1964 Jul; 64():1846-8. PubMed ID: 14154604 [No Abstract] [Full Text] [Related]
50. DRUG ADDICTION AND HABITUATION. AN INVESTIGATION WITH PERSONAL FOLLOW-UP OF 122 DRUG ADDICTED AND HABITUATED PATIENTS PREVIOUSLY TREATED IN A PSYCHIATRIC CLINICAL DEPARTMENT. RETTERSTOEL N; SUND A Acta Psychiatr Scand; 1964; 40():SUPPL 179:1+. PubMed ID: 14301940 [No Abstract] [Full Text] [Related]
51. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
52. Drug development for "orphan" diseases. Cerami A Am J Med; 1978 Sep; 65(3):407-8. PubMed ID: 717413 [No Abstract] [Full Text] [Related]
53. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States. J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945 [No Abstract] [Full Text] [Related]
54. United Kingdom Committee on safety of drugs. Pharmakotherapia; 1964; 2(1):207. PubMed ID: 5875714 [No Abstract] [Full Text] [Related]
55. [THE TOXICOLOGIC STUDY OF NEW DRUGS]. APARICIODOMINGUEZ L Arch Inst Farmacol Exp (Madr); 1963; 15():131-44. PubMed ID: 14122114 [No Abstract] [Full Text] [Related]
56. The evaluation of new drugs. Current Food and drug Administration regulations and statistical aspects of clinical trials. Barron BA; Bukantz SC Arch Intern Med; 1967 Jun; 119(6):547-56. PubMed ID: 6027182 [No Abstract] [Full Text] [Related]
58. GMPs vs GCPs: manufacturing and compounding definitions. Allen LV Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778 [No Abstract] [Full Text] [Related]
59. [PSYCHOSES AFTER USE OF METHYLPENTINOL]. URBAN H Dtsch Med Wochenschr; 1965 Feb; 90():391-4. PubMed ID: 14243126 [No Abstract] [Full Text] [Related]